As of June 1, 2026, there are 3,848 lawsuits pending in the federal multidistrict litigation (MDL) for general GLP-1 drug injuries and 146 pending lawsuits in the GLP-1 vision loss (NAION) MDL
Li D, Taniguchi EV, Cai S, Paschalis EI, Wang H, Miller JB et al
Answer Ozempic is the brand name for a drug called semaglutide, which is used for treatment of type 2 diabetes
What drugs are covered in these lawsuits
For instance, when activated, this receptor can trigger an increase in hormones called incretins, which work to: Help the body produce insulin, but only when needed Reduce the amount of unnecessary glucose (sugar) being released by the liver Slow the rate at which the stomach digests and empties food Reduce appetite, resulting in a reduced food intake Dosage and administration The first thing to be aware of is that you may know Semaglutide by its trade name Ozempic